Use of prostaglandin D.sub.2 -active substances

Details Use of prostaglandin D.sub.2 -active substances Use of prostaglandin D.sub.2 -active substances

1987-05-04

1989-04-25

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514530, 514573, 514913, A61K 31415, A61K 31215, A61K 3119, A61K 31557

Patent

active

048248576

ABSTRACT:
Method of treatment of ocular hypertension and glaucoma which comprises administering an effective amount of prostaglandin D.sub.2 -active substance to a subject in need of such treatment.

REFERENCES:
patent: 4599353 (1986-07-01), Bito
Chiryo 68, 1207-1213 (1986)-Translation of Column 1, Line 26-Column 2, Line 28.
Stern, E. A. et al., Invest., Opthalmol., Vis. Sci., 22, 588-598 (1982).
Kulkarni, P. S. et al., Invest. Opthalmol, Vis, Sci., 26, 1178-1182.
Bito, L. Z. Exp. Eye. Res., 38, 181-194, (1984).
Kulkarni, P. S., et al., Invest, Opthalmol, Vis. Sci., 23, 383-392 (1982).
Bito, L. Z., Exp. Eye Res., 39, 807-829 (1984).
Giuffre, G., Graefe's Arch. Clin. Exp. Opthalmol, 222, 139-141 (1985).
Van Alphen, G.W.H.M., et al., Doc. Opthamol, 42 397-415 (1977).
Masuda, K. et al., Japanese J. Opthamol., 17, 300-309, (1973).
Moses, R. A. et al., Ann. Opthalmol, 13, 721-723 (1981).
Camras, C. B. et al., Invest. Opthalmol., Vis. Sci., 16, 1125-1134 (1977).
Lee, Ping--yu, "Invest. Opthalmol & Vis. Sci.", 25, 1087-1093, 1984.

Affiliated with

Also associated with

Rating

Use of prostaglandin D.sub.2 -active substances does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of prostaglandin D.sub.2 -active substances, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of prostaglandin D.sub.2 -active substances will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1196065